References
- Da Forno PD, Fletcher A, Pringle JH et al. Understanding spitzoid tumours: new insights from molecular pathology. Br. J. Dermatol.158, 4–14 (2008).
- Da Forno PD. Molecular Pathology as a Tool to Determine Features of Clinico-Pathological Progression and Malignancy in Melanocytic Neoplasia. University of Leicester NHS Trust. Thesis/Dissertation (2007).
- Spitz S. Melanomas of childhood. Am. J. Pathol.24, 591–609 (1948).
- Ludgate MW, Fullen DR, Lee J et al. The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution. Cancer115, 631–641 (2009).
- Mones JM, Ackerman AB. “Atypical” blue nevus, “malignant” blue nevus, and “metastasizing” blue nevus: a critique in historical perspective of three concepts flawed fatally. Am. J. Dermatopathol.26, 407–430 (2004).
- Alexandroff AB, Burd R. Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology. Br. J. Dermatol. DOI: 10.1111/j.1365-2133.2009.09107.x (2009) (Epub ahead of print)
- Mones JM, Ackerman AB. Melanomas in prepubescent children: review comprehensively, critique historically, criteria diagnostically, and course biologically. Am. J. Dermatopathol.25, 223–238 (2003).
- Paniago-Pereira C, Maize JC, Ackerman AB. Nevus of large spindle and/or epithelioid cells (Spitz’s nevus). Arch. Dermatol.114, 1811–1823 (1978).
- Takata M, Lin J, Takayanagi S et al. Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion. Br. J. Dermatol.156, 1287–1294 (2007).
- Mihic-Probst D, Perren A, Schmid S et al. Absence of BRAF gene mutations differentiates Spitz nevi from malignant melanoma. Anticancer Res.24, 2415–2418 (2004).
- Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool. Dermatol. Ther.19, 40–49 (2006).
- Thomas JM. Prognostic false-positivity of the sentinel node in melanoma. Nat. Clin. Pract. Oncol.5, 18–23 (2008).
- Thomas JM. Sentinel lymph node biopsy in malignant melanoma. BMJ336, 902–903 (2008).
- Thomas JM. Concerns relating to the conduct and statistical analysis of the Multicenter Selective Lymphadenectomy Trial (MSLT-1) in patients with melanoma. J. Plast. Reconstr. Aesthet. Surg.62(4), 442–446 (2009).
- Alexandroff AB, Harman KE. Blistering skin disorders: an evidence-based update. Conference report. Br. J. Dermatol.160, 502–504 (2009).